Re: Second Amendment to Investment and Royalty AgreementEscrow Agreement • July 24th, 2009 • Columbia Laboratories Inc • Pharmaceutical preparations • Delaware
Reference is made to that certain Investment and Royalty Agreement made as of March 5, 2003, as amended by a letter agreement dated January 26, 2004, and supplemented by a letter agreement dated April 14, 2006 (the “Striant Agreement”).
COLUMBIA LABORATORIES, INC. WARRANT TO PURCHASE COMMON STOCKColumbia Laboratories Inc • July 24th, 2009 • Pharmaceutical preparations • New York
This Certifies That, for value received, PharmaBio Development Inc., with its principal office at 4820 Emperor Blvd, Durham, NC 27703, or its permitted assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from Columbia Laboratories, Inc., a Delaware corporation, with its principal office at 354 Eisenhower Parkway, Livingston, New Jersey 07039 (the “Company”), up to Nine Hundred Thousand (900,000) shares of common stock of the Company, par value $0.01 per share (the “Common Stock”), subject to adjustment as provided herein.
